一般社団法人日本呼吸器学会 公式サイト
日本呼吸器学会英文誌 Respiratory Investigation
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 検索用
日本呼吸器学会誌 増刊号 学術講演会プログラム 抄録集 全文PDF

Abstract

Full Text of PDF Full Text of PDF (924k)  required ID / password
Article in Japanese

Case Report

A case of KRAS mutation-positive invasive mucus-producing lung adenocarcinoma with high serum CA19-9 levels

Yuki Seikea  Kazuyoshi Watanabea  Task Iwabuchia  Tamami Sakaia  Seiji Yanob 

aDepartment of Respiratory Medicine, Japan Community Health Care Organization Kanazawa Hospital
bDepartment of Respiratory Medicine, Kanazawa University Hospital

ABSTRACT

The patient, a 77-year-old man, was diagnosed with invasive mucus-producing lung adenocarcinoma (cT4N3M1b stage IVA, KRAS G12C positive) and started chemotherapy with carboplatin, pemetrexed, and pembrolizumab. The tumors markedly reduced in size. Pembrolizumab-containing chemotherapy was effective in KRAS mutation-positive invasive mucus-producing lung adenocarcinoma.

KEYWORDS

Invasive mucinous adenocarcinoma  KRAS G12C  Pembrolizumab 

Received 16-Apr-24 / Accepted 28-Jun-24

AJRS, 13(5): 213-217, 2024

Google Scholar